Vimarsana
Biggest News Aggregation in the World

Mujeeb Jafferi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mujeeb Jafferi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mujeeb Jafferi Today - Breaking & Trending Today

Stella buys Field Trip ketamine assets | Crain's Chicago Business - Vimarsana News

Stella buys Field Trip ketamine assets | Crain's Chicago Business

Walgreens earnings disappoint, Augmedic's big venture-capital haul and more in today's Health Pulse.

Ketamine News: PharmaTher Begins FDA Filing For KETARX Application, Stella Acquires Field Trip Assets - PharmaTher Holdings (OTC:PHRRF), Field Trip Health (OTC:FTHWF) - Vimarsana News

Ketamine News: PharmaTher Begins FDA Filing For KETARX Application, Stella Acquires Field Trip Assets - PharmaTher Holdings (OTC:PHRRF), Field Trip Health (OTC:FTHWF)

Specialty biotech company PharmaTher Holdings Ltd. (OTCQB: PHRRF) has filed a pre-submission facility correspondence in advance of its Abbreviated New Drug Application (ANDA) for its novel racemic ketamine KETARX to the FDA.

Reunion Neuroscience : NOTICE OF SPECIAL MEETING OF SHAREHOLDERS - Form 6-K - Vimarsana News

Reunion Neuroscience : NOTICE OF SPECIAL MEETING OF SHAREHOLDERS - Form 6-K

NOTICE OF SPECIAL MEETING OF SHAREHOLDERS TO BE HELD ON JULY 12, 2023 AND MANAGEMENT INFORMATION CIRCULAR JUNE 13, 2023 ... | June 20, 2023

Field Trip Health & Wellness Provides Business Update And - Vimarsana News

Field Trip Health & Wellness Provides Business Update And

Post-quarter end, launched a refreshed version of the Company’s award-winning app for psychedelic guidance, renamed ‘Field Trip’, to include a number of...

Field Trip Health Ltd. Announces Intention to Separate the - Vimarsana News

Field Trip Health Ltd. Announces Intention to Separate the

Transaction will create two distinct emerging leaders in the psychedelics industry, one providing personalized care and the other developing next...